Janux Therapeutics (JANX) Treasury Shares (2020 - 2026)

Janux Therapeutics (JANX) has 5 years of Treasury Shares data on file, last reported at $1.2 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 92.53% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 92.53% increase from a year earlier, with the FY2025 full-year figure at $704869.0, up 106.19% from the prior year.
• Treasury Shares for Q1 2026 stood at $1.2 million, up from $704869.0 in the prior quarter.
• Over the last five years, Treasury Shares for JANX reached as high as $1.2 million in Q1 2026 and fell as low as $17500.0 in Q2 2024.
• Historically, Treasury Shares has averaged $538778.8 across 3 years, with a median of $651299.5 in 2025.
• Across the five-year window, Treasury Shares jumped 3909.44% in 2025 and surged 92.53% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $341847.0 in 2024, then surged by 106.19% to $704869.0 in 2025, then jumped by 64.74% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $1.2 million in Q1 2026, $704869.0 in Q4 2025, and $699467.0 in Q3 2025.